Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ono Pharmaceutical Co. Ltd
ClinicalTrials.gov Identifier:
NCT00311038
First received: April 3, 2006
Last updated: June 12, 2012
Last verified: June 2012

April 3, 2006
June 12, 2012
April 2006
Not Provided
  • heart rate
  • image quality
  • safety
Same as current
Complete list of historical versions of study NCT00311038 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT
Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice Computed Tomography (CT) Due to Suspected Coronary Artery Disease

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.

Not Provided
Interventional
Phase 2
Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Coronary Artery Disease
Drug: ONO-1101
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
90
Not Provided
Not Provided

Inclusion Criteria:

  1. 20-74 years old
  2. Heart rate less than 90 beats/min more than 70 beats/min at entering the CT room

Exclusion Criteria:

  1. Previous allergic reactions to contrast agent
  2. Renal failure
  3. Asthma
  4. Other exclusion criteria as specified in the protocol
Both
20 Years to 74 Years
No
Contact information is only displayed when the study is recruiting subjects
Japan
 
NCT00311038
ONO-1101-24
Not Provided
Ono Pharmaceutical Co. Ltd
Ono Pharmaceutical Co. Ltd
Not Provided
Study Director: Project Leaders Development Planning Ono Pharmaceutical Co. Ltd
Ono Pharmaceutical Co. Ltd
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP